Tag: life sciences
-
Start-Up Developing Immunometabolism Therapies, Gains $30M Funding
A start-up enterprise founded by medical researchers in the U.S. and Europe is developing treatments for cancer and autoimmune disorders that change chemical reactions in immune system cells.
-
Trials to Test Stem Cell Treatments for Eye Injuries
A series of clinical trials are planned to test the use of adult stem cells to treat injuries to the eyes that lead to vision loss.
-
Biotech in $3.7B Licensing Deal for Hepatitis-B
A biotechnology company developing therapies that silence the actions of disease-causing genes is licensing its treatment program for hepatitis-B to Janssen Pharmaceuticals.
-
Artificial Pancreas Controls Type 1 Diabetes Better Than Insulin Pump Alone
A clinical trial shows a closed-loop algorithm-controlled artificial pancreas system helps people with type 1 diabetes better control their blood sugar levels than a glucose sensor and insulin pump system alone.
-
Human Antibodies Devised for Snakebite Treatment
An academic-industry team in Europe and Central America assembled a group of human antibodies that protects lab mice against venomous toxins from a dangerous African snake.
-
Mayo Clinic, Helix Partner on Genomic Analysis
Mayo Clinic and the company Helix Opco are providing a genomic analysis service for Mayo Clinic patients seeking more detailed insights into their genetic make-up and health outlook.
-
Protein Delivered with Gold Nanoparticles Helps Fix Muscle Injuries
A bioengineering lab at Harvard University devised a technique using gold nanoscale particles to deliver a protein to reduce inflammation from muscle injuries in lab mice.
-
Genome Editing Offers Marketable Wild Tomato
The groundcherry, a wild tomato plant that its devotees say has a delicious and unusual flavor, could be grown on farms for sale to consumers thanks to a genome editing project at two New York research institutes.
-
FDA Clears Genomic Bone Marrow Test for Low-Level Cancer
1 Oct. 2018. The Food and Drug Administration on Friday authorized for marketing in the U.S. a system for high-speed analysis of bone marrow samples to find low levels of residual cancer cells. The agency’s announcement cleared the ClonoSeq assay developed by Adaptive Biotechnologies in Seattle to test for minimal residual disease levels in people…
-
Novartis, NGO Partner on Generic Antibiotics
Drug maker Novartis and a not-for-profit organization delivering antibiotics for low- and middle-income countries are collaborating on production of generic antibiotics for children.